{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:39:25Z","timestamp":1761061165086,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ejso.2020.10.039","type":"journal-article","created":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T02:18:53Z","timestamp":1604110733000},"page":"681-689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"PB","title":["Prognostic nomograms and risk classifications of outcomes in very early-stage hepatocellular carcinoma patients after hepatectomy"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2222-1889","authenticated-orcid":false,"given":"Long-Hai","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Chuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Dong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0135-851X","authenticated-orcid":false,"given":"Xue-Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Long","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao-You","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.ejso.2020.10.039_bib1","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"1027","key":"10.1016\/j.ejso.2020.10.039_bib2","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejso.2020.10.039_bib3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jhep.2019.08.025","article-title":"Epidemiology and surveillance for hepatocellular carcinoma: new trends","volume":"72","author":"Singal","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"10","key":"10.1016\/j.ejso.2020.10.039_bib4","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A\u00a0global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.ejso.2020.10.039_bib5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1053\/j.gastro.2019.02.049","article-title":"Surveillance for hepatocellular carcinoma: current best practice and future direction","volume":"157","author":"Kanwal","year":"2019","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.ejso.2020.10.039_bib6","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s12072-013-9454-z","article-title":"Small hepatocellular carcinoma: current and future approaches","volume":"7","author":"Cong","year":"2013","journal-title":"Hepatol Int"},{"issue":"2","key":"10.1016\/j.ejso.2020.10.039_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/hepr.12464","article-title":"Evidence-based clinical practice guidelines for hepatocellular carcinoma: the Japan society of hepatology 2013 update (3rd JSH-HCC guidelines)","volume":"45","author":"Kokudo","year":"2015","journal-title":"Hepatol Res"},{"issue":"1","key":"10.1016\/j.ejso.2020.10.039_bib8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"Electronic address eee and European association for the study of the L. EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.ejso.2020.10.039_bib9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin Liver Dis"},{"issue":"1","key":"10.1016\/j.ejso.2020.10.039_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-0030-1247133","article-title":"Current strategy for staging and treatment: the BCLC update and future prospects","volume":"30","author":"Forner","year":"2010","journal-title":"Semin Liver Dis"},{"issue":"9","key":"10.1016\/j.ejso.2020.10.039_bib11","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1158\/1078-0432.CCR-17-2899","article-title":"Adjuvant transarterial chemoembolization for HBV-related hepatocellular carcinoma after resection: a randomized controlled study","volume":"24","author":"Wang","year":"2018","journal-title":"Clin Canc Res"},{"issue":"1","key":"10.1016\/j.ejso.2020.10.039_bib12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13045-019-0794-6","article-title":"Emerging agents and regimens for hepatocellular carcinoma","volume":"12","author":"Zhu","year":"2019","journal-title":"J\u00a0Hematol Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2020.10.039_bib13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/SLA.0b013e31824856f5","article-title":"Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings","volume":"255","author":"Schnitzbauer","year":"2012","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.ejso.2020.10.039_bib14","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3390\/cancers12040791","article-title":"Embolotherapeutic strategies for hepatocellular carcinoma: 2020 update","volume":"12","author":"Kishore","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.ejso.2020.10.039_bib15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000488035","article-title":"Guidelines for diagnosis and treatment of primary liver cancer in China (2017 edition)","volume":"7","author":"Zhou","year":"2018","journal-title":"Liver Cancer"},{"key":"10.1016\/j.ejso.2020.10.039_bib16","first-page":"295","article-title":"Radiofrequency ablation versus resection for Barcelona clinic liver cancer very early\/early stage hepatocellular carcinoma: a systematic review","volume":"12","author":"He","year":"2016","journal-title":"Therapeut Clin Risk Manag"},{"issue":"12","key":"10.1016\/j.ejso.2020.10.039_bib17","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1111\/liv.14258","article-title":"Surgical resection versus radiofrequency ablation very early-stage HCC (<\/=2 cm Single HCC): a propensity score analysis","volume":"39","author":"Chu","year":"2019","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.ejso.2020.10.039_bib18","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/SLA.0000000000001178","article-title":"Surgical resection versus radiofrequency ablation for single hepatocellular carcinoma <\/= 2 cm in a propensity score model","volume":"263","author":"Liu","year":"2016","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.ejso.2020.10.039_bib19","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/hep.25832","article-title":"Resection of hepatocellular cancer <\/=2 cm: results from two Western centers","volume":"57","author":"Roayaie","year":"2013","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.ejso.2020.10.039_bib20","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jhep.2013.04.009","article-title":"Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma","volume":"59","author":"Cucchetti","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"11","key":"10.1016\/j.ejso.2020.10.039_bib21","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1245\/s10434-019-07580-9","article-title":"Prognosis after resection of Barcelona clinic liver cancer (BCLC) stage 0, A, and B hepatocellular carcinoma: a comprehensive assessment of the current BCLC classification","volume":"26","author":"Tsilimigras","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2020.10.039_bib22","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1245\/s10434-020-08452-3","article-title":"Recurrence patterns and outcomes after resection of hepatocellular carcinoma within and beyond the Barcelona clinic liver cancer criteria","volume":"27","author":"Tsilimigras","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2020.10.039_bib23","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.ejso.2019.03.043","article-title":"A\u00a0nomogram to predict early postoperative recurrence of hepatocellular carcinoma with portal vein tumour thrombus after R0 liver resection: a large-scale, multicenter study","volume":"45","author":"Zhang","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.10.039_bib24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jhep.2019.08.032","article-title":"Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis","volume":"72","author":"Berardi","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.ejso.2020.10.039_bib25","article-title":"Development and validation of a nomogram to preoperatively estimate post-hepatectomy liver dysfunction risk and long-term survival in patients with hepatocellular carcinoma","author":"Wang","year":"2020","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ejso.2020.10.039_bib26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/liv.14249","article-title":"Albumin-bilirubin grade-based nomogram of the BCLC system for personalized prognostic prediction in hepatocellular carcinoma","volume":"40","author":"Ho","year":"2020","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.ejso.2020.10.039_bib27","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jhep.2007.06.019","article-title":"Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma","volume":"47","author":"Sun","year":"2007","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.ejso.2020.10.039_bib29","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1245\/s10434-019-08025-z","article-title":"Utilizing machine learning for pre- and postoperative assessment of patients undergoing resection for BCLC-0, A and B hepatocellular carcinoma: implications for resection beyond the BCLC guidelines","volume":"27","author":"Tsilimigras","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2020.10.039_bib33","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/jjco\/hyz150","article-title":"A\u00a0review of changes to and clinical implications of the eighth TNM classification of hepatobiliary and pancreatic cancers","volume":"49","author":"Ueno","year":"2019","journal-title":"Jpn J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2020.10.039_bib34","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1440-1746.2010.06329.x","article-title":"Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian population","volume":"26","author":"Chan","year":"2011","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.ejso.2020.10.039_bib35","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1440-1746.2007.05075.x","article-title":"Comparison of three current staging systems for hepatocellular carcinoma: Japan integrated staging score, new Barcelona Clinic Liver Cancer staging classification, and Tokyo score","volume":"23","author":"Chung","year":"2008","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.ejso.2020.10.039_bib36","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1053\/he.2000.5628","article-title":"Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. The Cancer of the Liver Italian Program (CLIP) Investigators","volume":"31","year":"2000","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.ejso.2020.10.039_bib37","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E","article-title":"Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients","volume":"56","author":"Okuda","year":"1985","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2020.10.039_bib38","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00432-016-2286-1","article-title":"Novel microvascular invasion-based prognostic nomograms to predict survival outcomes in patients after R0 resection for hepatocellular carcinoma","volume":"143","author":"Feng","year":"2017","journal-title":"J\u00a0Canc Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.10.039_bib39","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12885-017-3050-x","article-title":"Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B","volume":"17","author":"Huang","year":"2017","journal-title":"BMC Canc"},{"issue":"4","key":"10.1016\/j.ejso.2020.10.039_bib40","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1245\/s10434-012-2739-y","article-title":"Microvascular invasion does not predict long-term survival in hepatocellular carcinoma up to 2 cm: reappraisal of the staging system for solitary tumors","volume":"20","author":"Shindoh","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2020.10.039_bib41","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/hepr.13241","article-title":"Microvascular invasion predicts a poor prognosis of solitary hepatocellular carcinoma up to 2 cm based on propensity score matching analysis","volume":"49","author":"Wang","year":"2019","journal-title":"Hepatol Res"},{"issue":"2","key":"10.1016\/j.ejso.2020.10.039_bib42","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/jso.24819","article-title":"Does the Pringle maneuver affect survival and recurrence following surgical resection for hepatocellular carcinoma? A western series of 441 patients","volume":"117","author":"Famularo","year":"2018","journal-title":"J\u00a0Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2020.10.039_bib43","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1111\/ajco.12585","article-title":"Continuous Pringle maneuver does not affect outcomes of patients with hepatocellular carcinoma after curative resection","volume":"13","author":"Xu","year":"2017","journal-title":"Asia Pac J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.10.039_bib44","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/jso.24271","article-title":"Longer duration of the Pringle maneuver is associated with hepatocellular carcinoma recurrence following curative resection","volume":"114","author":"Liu","year":"2016","journal-title":"J\u00a0Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2020.10.039_bib45","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1007\/s11605-017-3528-5","article-title":"Preoperative carbohydrate antigen 19-9: its neglected role in alpha-fetoprotein-negative hepatocellular carcinoma patients","volume":"21","author":"Lu","year":"2017","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"3","key":"10.1016\/j.ejso.2020.10.039_bib46","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.21873\/anticanres.11430","article-title":"Elevated preoperative serum CEA level is associated with poor prognosis in patients with hepatocellular carcinoma through the epithelial-mesenchymal transition","volume":"37","author":"Yoshikawa","year":"2017","journal-title":"Anticancer Res"},{"issue":"6","key":"10.1016\/j.ejso.2020.10.039_bib47","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/SLA.0000000000002727","article-title":"Antiviral therapy reduces hepatocellular carcinoma recurrence in patients with low HBV-DNA levels: a randomized controlled trial","volume":"268","author":"Huang","year":"2018","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ejso.2020.10.039_bib48","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41416-020-0864-0","article-title":"Nine-factor-based immunohistochemistry classifier predicts recurrence for early-stage hepatocellular carcinoma after curative resection","volume":"123","author":"Liu","year":"2020","journal-title":"Br J Canc"},{"key":"10.1016\/j.ejso.2020.10.039_bib49","article-title":"Early versus late recurrence of hepatocellular carcinoma after surgical resection based on post-recurrence survival: an international multi-institutional analysis","author":"Wei","year":"2020","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.ejso.2020.10.039_bib50","first-page":"1693","article-title":"Novel prognostic nomograms for predicting early and late recurrence of hepatocellular carcinoma after curative hepatectomy","volume":"12","author":"Xu","year":"2020","journal-title":"Canc Manag Res"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320308751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320308751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:35:38Z","timestamp":1760060138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798320308751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0748798320308751"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2020.10.039","relation":{},"ISSN":["0748-7983"],"issn-type":[{"type":"print","value":"0748-7983"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic nomograms and risk classifications of outcomes in very early-stage hepatocellular carcinoma patients after hepatectomy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2020.10.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}